Prothrombotic abnormalities in inflammatory bowel disease
Prothrombotic abnormalities in inflammatory bowel disease
复制标题
炎症性肠病的血栓前异常
DOI：
10.1007/bf01536380
复制
发表时间：
1989
影响因子：
3.1
通讯作者：
D. Burnett
中科院分区：
文献类型：
--
作者：
M. Conlan;W. Haire;D. Burnett
已知炎症性肠病（IBD）与血栓形成倾向相关，这通常归因于血小板增多、纤维蛋白原升高或抗凝血酶III降低。我们前瞻性研究了8例IBD患者，其中7例几乎没有或没有疾病活动，以确定他们是否有任何已知与血栓形成风险增加相关的实验室异常。5例患者出现纤溶抑制：4例患者血浆纤溶酶原激活物抑制物水平升高，1例患者静脉闭塞后组织纤溶酶原激活物释放不良。循环免疫复合物存在于5例患者的血清中。1例患者纤维蛋白原轻度升高，2例患者轻度血小板增多。未观察到抗凝血酶III、蛋白C或蛋白S水平降低。在非活动性IBD中，纤维蛋白溶解异常的发生率似乎很高，这可能导致IBD中血栓形成的频率很高。循环免疫复合物的存在可能导致血管损伤和血栓形成。
Inflammatory bowel disease (IBD) is known to be associated with a thrombotic tendency, which is often attributed to thrombocytosis, elevated fibrinogen, or decreased antithrombin III. We prospectively studied eight patients with IBD, seven of whom had little or no disease activity, to determine if they had any laboratory abnormality known to be associated with an increased risk of thrombosis. Abnormalities in fibrinolysis were noted in five patients: four with high plasminogen activator inhibitor levels and one with poor release of tissue plasminogen activator following venous occlusion. Circulating immune complexes were present in the sera of five patients. Fibrinogen was mildly elevated in one patient, and two patients had mild thrombocytosis. Decreased levels of antithrombin III, protein C, or protein S were not observed. There appears to be a high incidence of abnormalities in fibrinolysis in inactive IBD, which may contribute to the high frequency of thrombosis seen in IBD. The presence of circulating immune complexes may contribute to vascular injury and thrombosis.